ExodusPoint Capital Management’s Crescent Biopharma, Inc. Common Stock CBIO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q2 | – | Sell |
-357
| Closed | -$107K | – | 1548 |
|
2024
Q1 | $107K | Sell |
357
-601
| -63% | -$180K | ﹤0.01% | 1284 |
|
2023
Q4 | $226K | Buy |
+958
| New | +$226K | ﹤0.01% | 1183 |
|
2022
Q2 | – | Sell |
-107
| Closed | -$12K | – | 2060 |
|
2022
Q1 | $12K | Sell |
107
-186
| -63% | -$20.9K | ﹤0.01% | 2052 |
|
2021
Q4 | $42K | Buy |
293
+69
| +31% | +$9.89K | ﹤0.01% | 2005 |
|
2021
Q3 | $49K | Sell |
224
-388
| -63% | -$84.9K | ﹤0.01% | 1917 |
|
2021
Q2 | $142K | Buy |
612
+441
| +258% | +$102K | ﹤0.01% | 1997 |
|
2021
Q1 | $52K | Sell |
171
-380
| -69% | -$116K | ﹤0.01% | 1974 |
|
2020
Q4 | $207K | Buy |
+551
| New | +$207K | ﹤0.01% | 1641 |
|